Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-02-17

Clinical Trial Update: Impact of Evolocumab on the Effects of Clopidogrel in Patients With High On-Treatment Platelet Reactivity [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating how evolocumab influences the effects of clopidogrel in patients with high on-treatment platelet reactivity in atherosclerotic cardiova…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLOPIDOGREL (CLOPIDOGREL)
  • Evolocumab (evolocumab)

Snippet

Sponsor: University of Florida | Conditions: Atherosclerotic Cardiovascular Disease | Phase 4 | Status: COMPLETED | Results posted: 2022-02-17